Glucose control and vascular complications in veterans with type 2 diabetes

Duckworth, William, Abraira, Carlos, Moritz, Thomas, Reda, Domenic, Emanuele, Nicholas, Reaven, Peter D., Zieve, Franklin J., Marks, Jennifer +8 more·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0808431

Cited by (1,057)

Items 501–600 of 1,057

A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
Omar S. Ahmad, John A. Morris, Muhammad Hussain Mujammami, Vincenzo Forgetta, Aaron Leong, Rui Li, Maxime Turgeon, Celia M.T. Greenwood, George Thanassoulis, James B. Meigs et al. · 2015 · Nature Communications
External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?
Christopher Saunders, Christopher D. Byrne, Bruce Guthrie, Robert S. Lindsay, John A. McKnight, Sam Philip, Naveed A. Sattar, Jeremy J. Walker, Sarah H. Wild · 2012 · Diabetic Medicine
Exploring inhibitory mechanism of gallocatechin gallate on a-amylase and a-glucosidase relevant to postprandial hyperglycemia
Xiaqing Wu, Huafang Ding, Xing Hu, Junhui Pan, Yijing Liao, Deming Gong, Guowen Zhang · 2018 · Journal of Functional Foods
Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK/ERK signaling
Yi Fan Liu, Jingan Chen, Haowei Liang, Yueqin Cai, Xinyue Li, Yan Li, Lili Zhou, Letian Shan, Hui Wang · 2022 · Stem Cell Research & Therapy
A study of the natural history of diabetic kidney disease (DKD)
Nagi Altemtam, J. Russell, Meguid El Nahas · 2011 · Nephrology Dialysis Transplantation
Hypoglycemia and Cardiovascular Risk: Is There a Major Link?
M Hanefeld, Brian M. Frier, Frank Pistrosch · 2016 · Diabetes Care
Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
Mary E. Herman, James Henry O’Keefe, David S.H. Bell, Stanley S. Schwartz · 2017 · Progress in Cardiovascular Diseases
Treatment guide for diabetes
Kenzo Oba · 2011 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
A systematic review of risk factors for cataract in type 2 diabetes
Jocelyn J. Drinkwater, Wendy Angela Davis, Timothy M. E. Davis · 2018 · Diabetes/Metabolism Research and Reviews
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Mark O. Goodarzi, Jerome I. Rotter · 2020 · Circulation Research
Effect of ‘activity monitor-based’ counseling on physical activity and health-related outcomes in patients with chronic diseases: A systematic review and meta-analysis
Vaes, Anouk W., Cheung, Amy, Atakhorrami, Maryam, Groenen, Miriam T. J., Amft, Oliver, Franssen, Frits M. E., Wouters, Emiel F. M., Spruit, Martijn A. · 2013 · Annals of Medicine
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Anil Pareek, Nitin Chandurkar, Kumar Naidu · 2016 · New England Journal of Medicine
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Alberto Palazzuoli, Massimo Iacoviello · 2022 · Heart Failure Reviews
Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial
Pradhan, Aruna D., Everett, Brendan M., Cook, Nancy R., Rifai, Nader, Ridker, Paul M · 2009 · JAMA
SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory
Paneni, Francesco, Volpe, Massimo, Lüscher, Thomas Felix, Cosentino, Francesco · 2013 · Diabetes
Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany
Stephan Pscherer, F.W. Dippel, Silke Lauterbach, Karel Kostev · 2012 · Primary care diabetes
Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus
Brendan M. Everett, Nancy R. Cook, Maria Chiara Magnone, María Bobadilla, Eunjung Kim, Nader Rifai, Paul M. Ridker, Aruna D. Pradhan · 2011 · Circulation
Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice
Susan A. Marsh, Louis J. Dell’Italia, John C. Chatham · 2010 · Amino Acids
Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis
John Peter Mitsios, Elif Ilhan Ekinci, Gregory Peter Mitsios, Leonid P. Churilov, Vincent Thijs · 2018 · Journal of the American Heart Association
Thiazolidinedione Drugs and Cardiovascular Risks
Sanjay Kaul, Ann F. Bolger, David M. Herrington, Robert Patrick Giugliano, Robert H. Eckel · 2010 · Circulation
Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications
Maíra Viégas, Christiane Costa, Arthur Soares Lopes, Luiz Griz, Maria Antonieta Medeiro, Francisco Alfredo Farias Bandeira · 2011 · Journal of Diabetes and its Complications
Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery
David E. Cummings, RICARDO VITOR COHEN · 2014 · The Lancet Diabetes & Endocrinology
Hemoglobin A1c and Mortality in Older Adults With and Without Diabetes: Results From the National Health and Nutrition Examination Surveys (1988–2011)
Priya Palta, Elbert S. Huang, Rita Rastogi Kalyani, Sherita Hill Golden, Hsin‐Chieh Yeh · 2017 · Diabetes Care
A Unified Pathophysiological Construct of Diabetes and its Complications
Stanley S. Schwartz, Solomon Epstein, Barbara E. Corkey, Struan F.A. Grant, James R. Gavin, Richard B. Aguilar, Mary E. Herman · 2017 · Trends in Endocrinology and Metabolism
Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus—review and meta-analysis
Amanda Adler, Sebhat A. Erqou, T. A. S. Lima, Andrew H.N. Robinson · 2010 · Diabetologia
Interpreting and reporting clinical trials with results of borderline significance
Allan K. Hackshaw, Amy A. Kirkwood · 2011 · BMJ
Sex Differences in All-Cause and Cardiovascular Mortality, Hospitalization for Individuals With and Without Diabetes, and Patients With Diabetes Diagnosed Early and Late
Roche, Madonna M., Wang, Peizhong Peter · 2013 · Diabetes Care
Beyond HbA1c: comparing glycemic variability and glycemic indices in predicting hypoglycemia in type 1 and type 2 diabetes
Rama Chandran, Suresh, Tay, Wei Lin, Lye, Weng Kit, Lim, Lee Ling, Ratnasingam, Jeyakantha, Tan, Alexander Tong Boon, S.L. Gardner, Daphne · 2018 · Diabetes Technology & Therapeutics
Effects of Dapagliflozin on Cardiovascular Risk Factors
Agata Ptaszynska, Elise Hardy, EVA K. JOHNSSON, Shamik J. Parikh, James F. List · 2013 · Postgraduate Medicine
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach
Paolo Pozzilli, Richard David Leslie, Juliana C.N. Chan, R De Fronzo, L. Monnier, Itamar Raz, Stefano Del Prato · 2010 · Diabetes/Metabolism Research and Reviews
Lowering the Triglyceride/High-Density Lipoprotein Cholesterol Ratio Is Associated With the Beneficial Impact of Pioglitazone on Progression of Coronary Atherosclerosis in Diabetic Patients
Stephen James Nicholls, Emin Murat Tuzcu, Kathy Wolski, Özgür Bayturan, Andrea Lavoie, Kiyoko Uno, Stuart Kupfer, Alfonso Pérez, Richard W. Nesto, Steven E. Nissen · 2011 · Journal of the American College of Cardiology
Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects
Hassan Kahal, Anna Halama, Ahmed A. Aburima, Aditya Mukund Bhagwat, Alexandra E. Butler, Johannes Graumann, Karsten Suhre, Thozhukat Sathyapalan, Stephen Lawrence Atkin · 2020 · Scientific Reports
Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimerʼs Disease
Garth J. S. Cooper · 2011 · Drugs
Targets for Glycemic Control
Imran, S. Ali, Agarwal, Gina, Bajaj, Harpreet S., Ross, Stuart · 2018 · Canadian Journal of Diabetes
The Treatment of Type 2 Diabetes
Andreas F. H. Pfeiffer, Harald H. Klein · 2014 · Deutsches Ärzteblatt international
Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus
William David Strain, Xavier Cos, Michael Hirst, Sérgio Alberto Cunha Vencio, Viswanathan Mohan, Zoltán Vokó, Daisuke Yabe, Matthias Blüher, Päivi Maria Paldánius · 2014 · Diabetes Research and Clinical Practice
Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
Anna Grisold, Brian Christopher Callaghan, Eva L. Feldman · 2017 · Current Opinion in Endocrinology Diabetes and Obesity
Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms
Christina L. Aquilante · 2010 · Expert Review of Cardiovascular Therapy
The safety and tolerability of GLP‐1 receptor agonists in the treatment of type 2 diabetes: a review
Vanita R. Aroda, Robert E. Ratner · 2011 · Diabetes/Metabolism Research and Reviews
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
Sameer Ansar, Juraj Koška, Peter D. Reaven · 2011 · Cardiovascular Diabetology
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials
Francesco Giorgino, Anna Leonardini, Luigi Laviola · 2013 · Annals of the New York Academy of Sciences
Glucose targets for preventing diabetic kidney disease and its progression
Ruospo, Marinella, Saglimbene, Valeria M, Palmer, Suetonia C, De Cosmo, Salvatore, Pacilli, Antonio, Lamacchia, Olga, Cignarelli, Mauro, Fioretto, Paola, Vecchio, Mariacristina, Craig, Jonathan C et al. · 2017 · Cochrane Database of Systematic Reviews
Identifying Dysglycemic States in Older Adults: Implications of the Emerging Use of Hemoglobin A1c
Kasia J. Lipska, Nathalie de Rekeneire, Peter H. Van Ness, Karen Johnson, Alka M. Kanaya, Annemarie Koster, Elsa S. Strotmeyer, Bret H. Goodpaster, Tamara B. Harris, Thomas M. Gill et al. · 2010 · The Journal of Clinical Endocrinology & Metabolism
Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
Mahin Chowdhury, Sarah J Nevitt, Aikaterini Eleftheriadou, Prathap Kanagala, Hani Esa, Daniel James Cuthbertson, Abd A. Tahrani, Uazman Alam · 2021 · BMJ Open Diabetes Research & Care
Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity
David R. Webb, Kamlesh K. Khunti, R. Silverman, Laura J. Gray, B. T. Srinivasan, Peter S Lacy, Bryan Williams, Melanie Jane Davies · 2010 · Diabetologia
Glycemic Control and Burnt‐Out Diabetes in ESRD
Csaba Pal Kovesdy, Jong Chul Park, Kamyar Kalantar‐Zadeh · 2010 · Seminars in Dialysis
Fear of hypoglycemia---an underestimated problem
Przezak, Agnieszka, Bielka, Weronika, Molęda, Piotr · 2022 · Brain and Behavior
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus
Abhinav Sharma, Neha Jadeja Pagidipati, Robert M. Califf, Darren K. McGuire, Jennifer B. Green, Dave DeMets, Jyothis Thomas George, Hertzel C. Gerstein, Todd M. Hobbs, Rury R. Holman et al. · 2020 · Circulation
Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
Chang‐Sheng Sheng, Jingyan Tian, Ya Miao, Yi Cheng, Yulin Yang, Peter D. Reaven, Zachary T. Bloomgarden, Guang Ning · 2020 · Diabetes Care
Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study
Elder, Douglas H.J., Singh, Jagdeep S.S., Levin, Daniel, Donnelly, Louise A., Choy, Anna-Maria, George, Jacob, Struthers, Allan D., Doney, Alex S.F., Lang, Chim C. · 2016 · European Journal of Heart Failure
Haptoglobin Genotype Is a Consistent Marker of Coronary Heart Disease Risk Among Individuals With Elevated Glycosylated Hemoglobin
Leah E. Cahill, Andrew P. Levy, Stephanie E. Chiuve, Majken K. Jensen, Hong Wang, Nawar M. Shara, Shany Blum, Barbara V. Howard, Jennifer K. Pai, Kenneth Jay Mukamal et al. · 2013 · Journal of the American College of Cardiology
Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans
Nino Gogitidze Joy, Donna B. Tate, Lisa M. Younk, Stephen N. Davis · 2015 · Diabetes
Comprehensive approach to diabetic nephropathy
Bancha Satirapoj, Sharon G. Adler · 2014 · Kidney Research and Clinical Practice
New forms of insulin and insulin therapies for the treatment of type 2 diabetes
Avivit Cahn, Roberto Miccoli, Angela Dardano, Stefano Del Prato · 2015 · The Lancet Diabetes & Endocrinology
Novel metabolic biomarkers of cardiovascular disease
Majken K. Jensen, Monica L. Bertoia, Leah E. Cahill, Isha Agarwal, Eric B. Rimm, Kenneth Jay Mukamal · 2014 · Nature Reviews Endocrinology
Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment
Andrea Giaccari, Gian Pio Sorice, Giovanna Muscogiuri · 2009 · Nutrition Metabolism and Cardiovascular Diseases
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial
Viveca Ritsinger, Klas Malmberg, Anton Mårtensson, Lars Rydén, Hans Wedel, Anna Norhammar · 2014 · The Lancet Diabetes & Endocrinology
Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes
Peili Wu, Weiheng Wen, Jitong Li, Jie Xu, Min Zhao, Hong Chen, Jia Man Sun · 2019 · Hormone and Metabolic Research
Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes
David R. Owens · 2013 · Diabetes Technology & Therapeutics
Intensive versus intermediate glucose control in surgical intensive care unit patients
Okabayashi, Takehiro, Shima, Yasuo, Sumiyoshi, Tatsuaki, Kozuki, Akihito, Tokumaru, Teppei, Iiyama, Tasuo, Sugimoto, Takeki, Kobayashi, Michiya, Yokoyama, Masataka, Hanazaki, Kazuhiro · 2014 · Diabetes Care
Pharmacological Treatment and Current Management of Peripheral Artery Disease
Marc P. Bonaca, Mark A. Creager · 2015 · Circulation Research
Chronic Kidney Disease in Diabetes
Philip A. McFarlane, David Z.I. Cherney, Richard E. Gilbert, Peter Alexander Senior · 2018 · Canadian Journal of Diabetes
Intensive Multifactorial Intervention for Stable Coronary Artery Disease
David Joel Maron, William E. Boden, Robert A. O’Rourke, Pamela M. Hartigan, Karen J. Calfas, G.B. John Mancini, John A. Spertus, Marcin R. Dada, William J. Kostuk, Merril L. Knudtson et al. · 2010 · Journal of the American College of Cardiology
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
Mark A. Jarosinski, Balamurugan Dhayalan, Nischay K. Rege, Deepak Chatterjee, Michael Aaron Weiss · 2021 · Diabetologia
Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies
Steven P. Marso, Jason B. Lindsey, Joshua M. Stolker, John A. House, Gabriela Martinez Ravn, Kevin F. Kennedy, Troels Mygind Jensen, John B. Buse · 2011 · Diabetes and Vascular Disease Research
Antidiabetic Medications and Polypharmacy
Emily P. Peron, Kelechi C. Ogbonna, Krista L. Donohoe · 2014 · Clinics in Geriatric Medicine
Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
Francesco Paneni, Thomas Felix Lüscher · 2017 · The American Journal of Medicine
Risk factors for the presence and progression of cardiovascular autonomic neuropathy in type 2 diabetes: ADDITION-Denmark
Andersen, Signe T., Witte, Daniel R., Fleischer, Jesper, Andersen, Henning, Lauritzen, Torsten, Jørgensen, Marit E., Jensen, Troels S., Pop-Busui, Rodica, Charles, Morten · 2018 · Diabetes Care
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Clement Lo, Tadashi Toyama, Ying Wang, Jin Lin, Yoichiro Hirakawa, Min Jun, Alan Cass, Carmel Mary Hawley, Helen Pilmore, Sunil V. Badve et al. · 2018 · Cochrane Database of Systematic Reviews
Comparison between a basal‐bolus and a premixed insulin regimen in individuals with type 2 diabetes–results of the GINGER study
Andreas Fritsche, Martin Larbig, David R. Owens, Hans‐Ulrich Häring, on behalf of the GINGER study group · 2009 · Diabetes Obesity and Metabolism
Management of diabetic neuropathy
Simona Cernea, Itamar Raz · 2021 · Metabolism
Cardiometabolic Comorbidities in Cancer Survivors
Leah L. Zullig, Anthony Derek Sung, Michel Georges Khouri, Shelley A. Jazowski, Nishant P. Shah, Andrea Phillips Sitlinger, Dan V. Blalock, Colette A. Whitney, Robin Kikuchi, Hayden Barry Bosworth et al. · 2022 · JACC CardioOncology
A1C and Cardiovascular Outcomes in Type 2 Diabetes
Danielle C. Colayco, Fang Niu, Jeffrey S. McCombs, T. Craig Cheetham · 2010 · Diabetes Care
Progression of Vascular Calcification Is Increased With Statin Use in the Veterans Affairs Diabetes Trial (VADT)
Aramesh Saremi, Gideon Bahn, Peter D. Reaven, for the VADT Investigators · 2012 · Diabetes Care
Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: A systematic review for a KDOQI clinical practice guideline
Slinin, Yelena, Ishani, Areef, Rector, Thomas, Fitzgerald, Patrick, MacDonald, Roderick, Tacklind, James, Rutks, Indulis, Wilt, Timothy J. · 2012 · American Journal of Kidney Diseases
What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
Rodica Pop‐Busui · 2012 · Journal of Cardiovascular Translational Research
Treatment of type 2 diabetes mellitus in the elderly
Funda Datlı Yakaryılmaz, Zeynel Abidin Öztürk · 2017 · World Journal of Diabetes
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
Gerich · 2010 · Vascular Health and Risk Management
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Kalyani, Rita R. · 2021 · New England Journal of Medicine
Serious Cardiovascular Outcomes in Diabetes
Natalia Yakubovich, Hertzel C. Gerstein · 2011 · Circulation
Stroke and diabetes mellitus
Michael D. Hill · 2014 · Handbook of clinical neurology
Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
Ebell, Mark H., Barry, Henry C., Baduni, Kanishka, Grasso, Gabrielle · 2024 · The Annals of Family Medicine
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay, Samy Suissa · 2017 · Diabetes Care
The association between sustained HbA1c control and long-term complications among individuals with type 2 diabetes: a retrospective study
Boye, Kristina S., Thieu, Vivian T., Lage, Maureen J., Miller, Heather, Paczkowski, Rosirene · 2022 · Advances in Therapy
Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Katherine Esposito · 2019 · Journal of the American Heart Association
Pathophysiological Fundamentals of Diabetic Cardiomyopathy
Xinyue Hu, Tao Bai, Zheng Xu, Qiuju Liu, Yang Zheng, Lu Cai · 2017 · Comprehensive physiology
Cause-specific mortality in diabetes: recent changes in trend mortality
Khalil, Charbel Abi, Roussel, Ronan, Mohammedi, Kamel, Danchin, Nicolas, Marre, Michel · 2012 · European Journal of Preventive Cardiology
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up
Helen Heneghan, Derrick C. Cetin, Sankar Dass Navaneethan, Neil Orzech, Stacy A. Brethauer, Philip R. Schauer · 2012 · Surgery for Obesity and Related Diseases
Glycemic Control and Extended Hemodialysis Survival in Patients with Diabetes Mellitus
Mark E. Williams, Eduardo K. Lacson Jr., Weiling Wang, J. Michael Lazarus, Raymond M. Hakim · 2010 · Clinical Journal of the American Society of Nephrology
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
Rhonda Bentley–Lewis, David A. Aguilar, Matthew C. Riddle, Brian Lee Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Peter Johnston, Lars Køber, Francesca C. Lawson et al. · 2015 · American Heart Journal
Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy
Prodromos Parasoglou, Smita Rao, Jill M. Slade · 2017 · Clinical Therapeutics
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
Guntram Schernthaner, Marie Helene Schernthaner-Reiter · 2018 · Diabetologia
Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
Ferdinando Carlo Sasso, Luca Rinaldi, Nadia Lascar, Aldo Marrone, Pia Clara Pafundi, Luigi Elio Adinolfi, Raffaele Marfella · 2018 · Journal of Diabetes Research
Update on biomarkers of glycemic control
Krhač, Maja, Lovrenčić, Marijana Vučić · 2019 · World Journal of Diabetes
Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of healthcare interventions in primary care and community settings
Murphy, Mark E, Byrne, Molly, Galvin, Rose, Boland, Fiona, Fahey, Tom, Smith, Susan M · 2017 · BMJ Open
Does Aggressive Glycemic Control Benefit Macrovascular and Microvascular Disease in Type 2 Diabetes?: Insights from ACCORD, ADVANCE, and VADT
T Terry, Kalyani Raravikar, Nalurporn Chokrungvaranon, Peter D. Reaven · 2011 · Current Cardiology Reports
Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus
Paul R. Conlin, Jeffrey A. Colburn, David Clark Aron, Rose Mary Pries, Mark P. Tschanz, LEONARD M. POGACH · 2017 · Annals of Internal Medicine
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases
Masakazu Yamagishi, Nagara Tamaki, Takashi Akasaka, Takanori Ikeda, Kenji Ueshima, Shiro Uemura, Yutaka Otsuji, Yasuki Kihara, Kazuo Kimura, Takeshi Kimura et al. · 2021 · Circulation Journal
Mortality Rates in Trials of Subjects With Type 2 Diabetes
Ebrahim Barkoudah, Hicham Skali, Hajime Uno, Scott David Solomon, Marc Alan Pfeffer · 2012 · Journal of the American Heart Association
Are targeted therapies for diabetic cardiomyopathy on the horizon?
Mitchel Tate, David Grieve, Rebecca Helen Ritchie · 2017 · Clinical Science